Annovis Bio ANVS
NYSE ANVS
$1.20 -0.07 (-5.91%)
As of: Oct 1, 2026 · 3:08 PM EDT

Annovis Bio (ANVS) Preferred Stock Liabilities (2019)

Updated

Annovis Bio (ANVS) posted Preferred Stock Liabilities of $7.08 million for Q4 2019, unchanged from the prior quarter.

Analysis

Annovis Bio (ANVS) Preferred Stock Liabilities (2019) Analysis & Trends

Since Q1 2019, Annovis Bio has reported Preferred Stock Liabilities for 4 quarters.

  • According to Business Quant data, Preferred Stock Liabilities for the three prior quarters was $7.08 million (Q3 2019), $7.08 million (Q2 2019) and $7.08 million (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Annovis Bio 54.11 Mn 54.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 7.08 Mn
Sep 30, 2019 7.08 Mn
Jun 30, 2019 7.08 Mn
Mar 31, 2019 7.08 Mn
API Access

Annovis Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ANVS&period=max&api_key=YOUR_API_KEY